| pubmed-article:16425056 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16425056 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16425056 | lifeskim:mentions | umls-concept:C0032659 | lld:lifeskim |
| pubmed-article:16425056 | lifeskim:mentions | umls-concept:C0600097 | lld:lifeskim |
| pubmed-article:16425056 | lifeskim:mentions | umls-concept:C0010340 | lld:lifeskim |
| pubmed-article:16425056 | lifeskim:mentions | umls-concept:C0444889 | lld:lifeskim |
| pubmed-article:16425056 | lifeskim:mentions | umls-concept:C1709518 | lld:lifeskim |
| pubmed-article:16425056 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:16425056 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:16425056 | pubmed:dateCreated | 2006-3-9 | lld:pubmed |
| pubmed-article:16425056 | pubmed:abstractText | The objective of the present investigation was to develop a population pharmacodynamic model for midazolam- and lorazepam-induced sedation upon long-term continuous infusion in critically ill patients. | lld:pubmed |
| pubmed-article:16425056 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16425056 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16425056 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16425056 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16425056 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16425056 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16425056 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16425056 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16425056 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:16425056 | pubmed:issn | 0031-6970 | lld:pubmed |
| pubmed-article:16425056 | pubmed:author | pubmed-author:ZuideveldKlaa... | lld:pubmed |
| pubmed-article:16425056 | pubmed:author | pubmed-author:DanhofMeinder... | lld:pubmed |
| pubmed-article:16425056 | pubmed:author | pubmed-author:SwartEleonora... | lld:pubmed |
| pubmed-article:16425056 | pubmed:author | pubmed-author:ThijsLambertu... | lld:pubmed |
| pubmed-article:16425056 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:16425056 | pubmed:author | pubmed-author:Strack van... | lld:pubmed |
| pubmed-article:16425056 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16425056 | pubmed:volume | 62 | lld:pubmed |
| pubmed-article:16425056 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16425056 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16425056 | pubmed:pagination | 185-94 | lld:pubmed |
| pubmed-article:16425056 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:meshHeading | pubmed-meshheading:16425056... | lld:pubmed |
| pubmed-article:16425056 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16425056 | pubmed:articleTitle | Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients. | lld:pubmed |
| pubmed-article:16425056 | pubmed:affiliation | Department of Pharmacy, Vrije Universiteit Medical Center, Amsterdam, The Netherlands. el.swart@vumc.nl | lld:pubmed |
| pubmed-article:16425056 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16425056 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:16425056 | pubmed:publicationType | Comparative Study | lld:pubmed |
